ဆီးခ်ိဳေရာဂါေဆးေတြၿပီလို႔ တရားဝင္ေၾကျငာ

(သတင္းတင္ထားတဲ့ေန့စြဲက ၂၀၁၆ ကျဖစ္ပါတယ္။ တကယ္ပဲဆီးခ်ိဳးေပ်ာ္ကေဆးကိုေတြ့ျပီဆိုရင္ေတာ့ ၀မ္းသာစရာသတင္းျဖစ္ပါတယ္) ဆီးခ်ိဳေရာဂါေဆးေတြၿပီလို႔ !!!!တရားဝင္ေၾကျငာ
တကမၻာလံုးဝမ္းေျမာက္ၾကရမဲ့သတင္းပါ။
ေအာက္မွာဆက္ဖတ္သြားပါ

The Vaccine Against Diabetes Has Been Officially Announced And The Entire World Is Celebrating The News!
- 25/11/2016
- In Uncategorized

ဆီးခ်ိဳေရာဂါ တကမၻာလံုးအလြန္အကြၽံျဖစ္လာေနတာ ကပ္ေရာဂါအသြင္ေပါက္ေနၿပီဆိုတဲ့အေၾကာင္း
ေရာဂါနဲ႔ပိုးမႊား ၃ မွာတုန္းကေရးခဲ့ၿပီ။

အေမရိကန္တစ္ႏိုင္ငံထဲမွာတင္ဆီးခ်ိဳေရာဂါအမ်ိဳးအစား၁ သမား၁.၂၅သန္းရိွေနတာ။
ဆီးခ်ိဳအမ်ိဳးအစား၁၊၂စသည္အေၾကာင္းေရာဂါနဲ႔ပိုးမႊား၂ထဲၾကည့္ပါ။

In the United States alone, 1.25 million people suffer from type 1 diabetes.
ရလိုက္တဲ့ကာကြယ္ေဆးကအသစ္ထြင္ရတာမဟုတ္ဘူး။လြန္ခဲ့တဲ့ႏွစ္၁၀၀က TB တီဘီ အဆုတ္ေရာဂါကာကြယ္ေဆးအရည္ကိုပဲထိုးသြင္းစမ္းၾကည့္ရင္း ခုခံအားစႏွစ္ကေန
ဆက္ျဖစ္လာမႈေတြကိုေစာင့္ၾကည့္ကာဆီးခ်ိဳအမ်ိဳးအစား၁အတြက္အဆင္ေျပတာသိလာခဲ့ၾကတာ။ဒီတီဘီေဆးကိုပဲ ဆီးအိတ္ကင္ဆာကုေဆးအျဖစ္သံုးႏိုင္ခဲ့ဖူးတာေတြ႔ရိွခဲ့ဖူးၿပီးသား။
A vaccine used over 100 years ago for tuberculosis (bacillus Calmette-Guerin ) has shown promise in reversing this disease. This vaccine is now commonly used for treating bladder cancer and is considered to be safe.
ေၾကျငာမႈကိုအေမရိကန္ဆီးခ်ိဳအဖြဲ႔ရဲ႕၇၅ႀကိမ္ေျမႇာက္သိပၸံက႑ကေန ၂၀၁၆ႏိုဝင္ဘာ၂၄ရက္ေန႔ကေၾကျငာလိုက္တာပါ။အလြန္ေရာဂါျပင္းေနၿပီျဖစ္တဲ့ဆီးခ်ိဳအမ်ိဳးအစား၁လူနာ၁၅၀ကိုဒီေဆးထိုး
ၾကည့္လို႔ ေအာင္ျမင္ေကာင္းမြန္လာတာေတြ႔ရလို႔အစားအေသာက္နဲ႔ေဆးဝါးၫႊန္ၾကားေရးဌာန
အက္ဖ္ဒီေအ FDAကအတည္ျပဳလိုက္ၿပီ။
An announcement made yesterday at the 75th Scientific Sessions of the American Diabetes Association said that the FDA will test the vaccine on 150 people who are in an advanced stage of type one diabetes.
ဆီးခ်ိဳအမ်ိဳးအစား၁ျဖစ္ေနတဲ့လူ႔ခႏၶာကိုယ္မွာသူ႔ရဲ႕ကိုယ္ခံအားစႏွစ္က အင္ဆူလင္ထုတ္တဲ့ဆဲလ္ေတြကိုသတ္ပစ္လိုက္ၾကလို႔ အင္ဆူလင္မထုတ္ႏိုင္ဘဲျဖစ္ရတာ။
ပန္ကရိယအစြန္းစြယ္ေလးထဲျပႆနာျဖစ္ေစတဲ့တီဆဲလ္ T cells ေတြကိုအင္ဆူလင္ေတြထုတ္ရမဲ့အစားထုတ္ေနမိတဲ့သေဘာပါ။ခုေဆးရည္က အဲ့ဒီတီဆဲလ္ေတြကိုဖယ္႐ွင္းေပးတဲ့ဂုဏ္သတၱိရိွ
ေနတဲ့သေဘာပါ။
The body of a person with type 1 diabetes does not produce insulin due to the immune system destroying the cells that create insulin. T cells are produced, and these cells create problems in the pancreatic islets, where insulin is produced. The vaccine works by eliminating these T cells.
ဆီးခ်ိဳအမ်ိဳးအစား၁ရိွေနတဲ့လူနာကိုဒီေဆးထိုးသြင္းလိုက္တဲ့အခါ အက်ိတ္အလံုးမူးေဝေစတဲ့ပစၥည္းပမာဏေတြတိုးလာတာေတြ႔ရၿပီး ခႏၶာကိုယ္ထဲကဒီ TNFပမာဏတိုးမႈက အင္ဆူလင္ထုတ္လုပ္မႈကို
အေႏွာက္အယွက္ေပးေနတဲ့တီဆဲလ္ေတြကိုဖ်က္ဆီးေပးတာပါ။
Patients with diabetes injected with the vaccine saw an increase in the levels of a substance called tumor necrosis factor. The increased level of TNF in the system destroys the T cells that are hindering the production of insulin.
အရင္စမ္းသပ္မႈမွာ လူနာကို တီဘီေဆး၄ပတ္အတြင္း၂ႀကိမ္ထိုးသြင္းေပးရာ
ရလာဒ္ကတီဆဲလ္ေတြေပ်ာက္ကုန္တာပဲ။ေနာက္ၿပီးအင္ဆူလင္ေတြသူ႔ဖာသာျပန္ထြက္လာတာပဲ။
In a previous trial, patients were injected with the tuberculosis vaccine twice within a four-week time frame. The results showed that the dangerous T cells were gone, and some people even began to secrete insulin on their own.
ေဘာ္စတြန္မွာရိွတဲ့ မန္ဆာခ်ဴးဆက္ အေထြေထြေဆးရံုႀကီးက ကိုယ္ခံအားဇီဝေဗဒ
စမ္းသပ္ခန္းက ၫႊန္ၾကားေရးမႉးေဒါက္တာဒင္ႏိုက္စ္ဟာခု ဘီစီဂ်ီေဆးအတြက္ေတာ္ေတာ္စိတ္လႈပ္႐ွားခဲ့ၿပီး
Dr. Denise Faustman, director of the Massachusetts General Hospital Immunobiology Laboratory in Boston, is very excited about the results the BCG vaccine has been showing.
ဒီအဆင့္၁ အေျခခံအႀကိဳစမ္းသပ္မႈမွာစာရင္းဇယားအရ က်ေနာ္တို႔ ဘီစီဂ်ီ ကိုအားႀကီးႀကီးနဲ႔တုန္႔ျပန္ႏိုင္မႈကိုေတြ႔ခဲ့ၾကၿပီ။
ဒါေပမဲ့က်ေနာ္တို႔ပန္းတိုင္က အၿပီးသပ္ကုသႏိုင္မႈကိုပါ။က်ေနာ္တို႔ဆီးခ်ိဳအမ်ိဳးအစား၁ရိွေနတာႏွစ္႐ွည္ၾကာၿပီျဖစ္တဲ့လူနာေတြနဲ႔က်ေနာ္တိုထပ္လုပ္ၾကည့္ၾကမယ္ဗ်ာ။ဒါဟာကာကြယ္ေရးႀကိဳးစားမႈမဟုတ္ဘူး။ေရာဂါအရင့္စားကိုေတာင္ကုႏိုင္မဲ့စမ္းသပ္မႈပါ။လို႔သူကေျပာခဲ့တာ။
“In the phase I (preliminary) trial we demonstrated a statistically significant response to BCG, but our goal in (this trial) is to create a lasting therapeutic response. We will be working again with people who have had type 1 diabetes for many years. This is not a prevention trial; instead, we are trying to create a regimen that will treat even advanced disease” explained Dr. Denise.
စမ္းသပ္မႈအသစ္မွာ အသက္၁၈ႏွစ္နဲ႔၆၀ၾကားလူမမာေတြကိုအရင္ပံုစံနဲ႔ထပ္စမ္းၾကဦးမွာပါ။
၄ပတ္မွာ၂ႀကိမ္နႈံးနဲ႔လည္းထိုးမယ္၊၄ႏွစ္၁ခါထပ္ထုးိတာလည္းထပ္လုပ္ၾကည့္ၾကမယ္။
There’s a new trial coming which will use the same format as the previous one, on people at the age between 18 and 60. The subjects will be injected with the vaccine twice in a period of 4 weeks, and then once a year for a 4-year time span.
အရင္ရလာဒ္က ၅ႏွစ္နဲ႔၁၈ႏွစ္ၾကားလူငယ္ေတြစမ္းၿပီးရခဲ့တာ။
The Diabetes Care journal has published the results of a past study which analyzed the effects of Bacillus Calmette-Guerin (BCG) on kids with diabetes at the age between 5 and 18. The results showed that the BCG vaccine doesn’t keep the beta-cell function or raise the remission rate in kids.
http://homeremedieshouse.com/2016/11/vaccine-diabetes-officially-announced-entire-world-celebrating-news.html

Source: healthyfoodplans.net
Credit Aung Ko